The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States

by Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs
Published 2019-07-01

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

by Wayne Weng, Ye Tian, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs
Published 2020-03-01

The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes

by Wayne Weng, Sheldon X. Kong, Rahul Ganguly, Malene Hersloev, Jason Brett, Todd Hobbs, Florian M.M. Baeres
Published 2020-04-01

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

by Kevin M. Pantalone, Anita D. Misra-Hebert, Todd M. Hobbs, Xinge Ji, Sheldon X. Kong, Alex Milinovich, Wayne Weng, Janine Bauman, Rahul Ganguly, Bartolome Burguera, Michael W. Kattan, Robert S. Zimmerman
Published 2018-04-01

Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013

by Kevin M. Pantalone, Todd M. Hobbs, Brian J. Wells, Sheldon X. Kong, Michael W. Kattan, Jonathan Bouchard, Kevin M. Chagin, Changhong Yu, Brian Sakurada, Alex Milinovich, Wayne Weng, Janine M. Bauman, Robert S. Zimmerman
Published 2016-06-01

Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013

by Kevin M. Pantalone, Todd M. Hobbs, Brian J. Wells, Sheldon X. Kong, Michael W. Kattan, Jonathan Bouchard, Kevin M. Chagin, Changhong Yu, Brian Sakurada, Alex Milinovich, Wayne Weng, Janine M. Bauman, Robert S. Zimmerman
Published 2016-01-01